DBV Technologies To Conduct New Pivotal Trial For Peanut Allergy Patch, Shares Plunge To 52-Week Low<blockquote>DBV Technologies将对花生过敏贴剂进行新的关键试验,股价暴跌至52周低点</blockquote>
'Trapped' investors, here's your chance to escape one overplayed group of stocks, says strategist<blockquote>策略师表示,“被困”的投资者,这是你逃离一组被高估的股票的机会</blockquote>